Highlights

• Net operating income per share up 46% to $2.78, driven by solid underwriting performance across all lines, driven in part by benign weather, and strong distribution results
• Healthy premium growth of 8% driven by strong retention and new business and including The Guarantee Company of North America ("The Guarantee") acquisition
• Relief efforts helped more than 1.2 million customers, with $510 million provided year-to-date, including the recently launched $50 million targeted relief program for our most vulnerable small business customers
• OROE of 16.9% and BVPS up 4% in the quarter to $56.22
• Strong capital position with $1.9 billion of total capital margin available to manage potential further shocks and capture strategic opportunities

TORONTO, October 14, 2020 – Intact Financial Corporation (TSX: IFC) officially brings together its Canadian and U.S. specialty capabilities under a single brand: Intact Insurance Specialty Solutions. Unifying its specialty operations under one brand represents the full integration of this growing segment of Intact’s portfolio and its commitment to being a leader in the specialty lines marketplace.

The business landscape has changed drastically over the past several months as the world has struggled to combat and adapt to a global health crisis. Many organizations successfully pivoted their workforce to remote work, some even reporting increased productivity as a result. While there may be some positive outcomes of this forced remote environment as companies reconsider their flexible work arrangements and dollars spent on office space, unintended consequences and risks may also emerge.

Read complete article by Intact Management Liabilty's Brian Lester published in the Insurance Journal.

Medicine plays a vital role in safeguarding public health throughout the world. Pharmaceutical companies develop medicines to treat and cure sickness and disease. However, despite these noble intentions, occasionally substances created for a specific therapeutic purpose become dangerous. Heroin, for example, was introduced in 1898 as a therapeutic drug but was later determined to be highly addictive, leading to significant abuse. Since then, numerous pharmaceuticals products developed for specific therapeutic uses have been proven to be moderately to highly addictive, resulting in overdoses and deaths.